Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 01 Jul 2026 for Contineum Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Tim Watkins: trading record in brief
All filings by Tim Watkins on record concern Contineum Therapeutics, Inc., in the capacity of senior executive. The record holds 5 filings, for trades running from 29 December 2025 to 30 June 2026.
The open-market record consists of 1 sale, with no purchase. The totals exclude 1 filing filed without an amount. Besides market trades, the filings include 4 option exercises. 2026 to date brings no purchases and 1 sale.
The latest filing, published on 1 July 2026, reports an option exercise in Contineum Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Tim Watkins
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
10,833 sharesClass A Common StockSEC:0001628280-26-046654:0
10,833 sharesClass A Common StockSEC:0001628280-26-046654:1
3,611 shares@ US$4.5033.6% of flowClass A Common StockSEC:0001437749-26-006421:0
3,611 shares@ US$4.500.0032% mcap24.7% of flowClass A Common StockSEC:0001437749-26-002575:0
3,611 shares@ US$4.500.0032% mcap25.3% of flowClass A Common StockSEC:0001437749-25-038938:0
5 of 5 declarations
